Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07450807) titled 'Prospective Randomized Controlled Pilot Study of Gut Microbiome Modulation by Nigella Sativa Seed Oil and Thymoquinone Metabolism in Healthy Volunteers' on March 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Aysun Tekbas

Condition: Changes in Human Gut Microbiome in Healthy Adults

Intervention: Dietary Supplement: Intake of Thymoquinone (TQ) containing Nigella Sativa Seed Oil (NSSO) capsules

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 2, ...